@kavi_deniz: We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer…
Summary
TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab 2.0, Eli Lilly's collaborative AI/ML drug discovery platform.
View Cached Full Text
Cached at: 06/11/26, 09:42 PM
We’re proud to share that @TamarindBio has been selected to build, host, and operate the inference infrastructure layer for TuneLab2.0, the next evolution of the platform. @EliLillyandCo TuneLab is a first-of-its-kind, collaborative AI/ML drug discovery platform, bringing models trained on over $1B worth of Lilly proprietary data to the biotech ecosystem.
Tamarind will power TuneLab’s scalable drug discovery workflows and model inference.
Similar Articles
@danshipper: we @every make investments every so often in founders building things in AI who we think are excellent @ninklefitz is o…
Nicole Fitzgerald announces Tacit Labs, a new applied research lab at the intersection of AI and biology, with investment from Every.
@rohanpaul_ai: Quite a massive inferencing rack breakthrough from @TensordyneInc . They just announced an AI-inference rack, claiming …
Tensordyne announces the Napier AI inference rack, claiming 13x the throughput of Nvidia's NVL72 GB300 by using log-space math to reduce energy and transistor usage, potentially disrupting the inference hardware landscape.
@alexshander03: We’re launching @JudgmentLabs today and announcing $32M in funding. As AI agents take on more of the work that creates …
Judgment Labs is launching today with a $32M funding round, providing infrastructure to improve AI agents using production data.
Accelerating discovery of liver disease mechanisms
DeepMind's Co-Scientist AI system helped researchers at the University of Edinburgh generate a novel, experimentally verified hypothesis linking the NLRP3 inflammasome to the mechanism of drug resmetirom in MASH liver disease, potentially enabling targeted combination therapies.
Benchmarking Biology’s AI Agent: ML@B's Collaboration with LatchBio
Machine Learning at Berkeley collaborated with LatchBio to benchmark their AI agent's performance on spatial transcriptomics workflows, evaluating its ability to automate complex bioinformatics tasks.